Exparel 133 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26FCYT7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,044
Award facts
- Contract value 100% obligated
- $9,044.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $9,044.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. This delivery order, awarded on October 20, 2025, represents one of numerous pharmaceutical procurement actions issued to the vendor during October 2025. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The ultimate completion date is November 10, 2025, with performance to be executed at the vendor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy established to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. The underlying IDC, designated SPE2DR and awarded November 13, 2025, carries a ceiling value of $499.999 billion and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. EXPAREL, a specialty surgical anesthetic product included within the vendor's comprehensive pharmaceutical portfolio, supports the Defense Logistics Agency's mission to efficiently distribute the diverse pharmaceutical and medical consumable requirements essential to military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FCYT7?
SPE2DR26FCYT7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DR26FCYT7 worth?
The government has obligated $9,044 on SPE2DR26FCYT7.
Is contract SPE2DR26FCYT7 an order under another contract?
Yes. SPE2DR26FCYT7 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYT7 competed?
The extent of competition for SPE2DR26FCYT7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award